Snus Reviews By Larry Waters & Friends
While American Snus has only been designed and manufactured in the past few years, Sweden, the original inventor of snus, has been in existence for over 200 years.
Thus a great number of papers, studies, especially long term studies, on the health effects of Swedish Snus have been documented and are available today.
These links will take you to a number of them as well as other information of interest concerning Swedish Snus and the early studies on some of the original American-manufactured Snus.
Since Swedish Snus is regulated as a Food Product by the Swedish Government, it must meet strict quality and manufacturing standards. The major by-product of this is that Swedish Snus has the lowest levels of TSNA's (carcinogens which naturally occur in tobacco) than snus made by other methods and enormously lower than most chewing tobacco or other forms of oral tobacco.
| # | Web Link |
|---|---|
| 1 |
 Effect of smokeless tobacco (snus) on smoking and public health in Sweden
Authors’ affiliations: J Foulds, M Burke, University of Medicine and Dentistry of New Jersey-School of Public Health, Tobacco Dependence Program, New Brunswick,New Jersey, USAL Ramstrom, Institute for Tobacco Studies, Stockholm, SwedenK Fagerström, Fagerstrom Consulting and The Smokers InformationCenter, Helsingborg, Sweden |
| 2 |
Is Low-Nicotine Marlboro Snus really Snus? An article by Jonathan Foulds and Helena Furberg on low-nicotine Marlboro snus. Larry Waters has actually made the same case on Marlboro and by extension most American snus brilliantly with more detail and piercing insights. He does not have the educational credentials of Foulds and Furberg so now you can rest assured Larry and his articles are correct. |
| 3 |
Smoking Reduction/Cessation through Snus: SM 07-01
Serbian Trials: The study aims to assess if use of a low-nitrosamine, Swedish, smokefree tobacco product for oral use ("snus") can increase the quit rate among cigarette smokers who wish to stop smoking |
| 4 |
Smoking Reduction/Cessation through Snus: SM 08-01
American Trials: The study aims to assess if use of a low-nitrosamine, Swedish, smokefree tobacco product for oral use ("snus") can increase the quit rate among cigarette smokers who wish to stop smoking |
| 5 |
Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study
Affiliations: a. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE 171 77, Stockholm, Sweden b. Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Box 281, SE 171 77, Stockholm, Sweden c. Cancer Institute Research Center, Medical Sciences/University of Tehran, Tehran, Iran d. Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA e. International Agency for Research on Cancer, Lyon, France |
| 6 |
The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product Compared with Smoking Cigarettes: Estimates of a Panel of Experts
Cancer Epidemiology Biomarkers & Prevention Vol. 13, 2035-2042, December 2004 © 2004 American Association for Cancer Research |
| 7 |
Swedish National Institute of Public Health
Among other responsibilities, the Swedish Government has charged SNIPH with oversight of the Swedish snus industry. |
| 8 |
Response to: Enabling Good Health for A reflection process for a new EU Health Strategy
Report prepared for and found on the EU website by Institute for Tobacco Studies,Director and Principal Investigator, Lars M. Ramström Ph.D. |
| 9 |
Response to: EU Green Paper; Toward a Europe Free From Tobacco Smoke: Policy Options at the EU Level
International Smokeless Tobacco Company Inc. submission to relation to EU Green Paper, 1 May 2007 |
| 10 |
Questions from the Austrian Smokers Network to the EU Health Commission
While published on the EU website, the studies sighted made the European Commission on Health uncomfortable enough to put a disclaimer at the end of the questions. |
| 11 |
Swedish Tobacco Use: Smoking, Smokeless, and History
Dr. Rodu is a professor of pathology at the University of Alabama at Birmingham. |
| 12 |
Should doctors advocate snus and other nicotine replacements? Yes
John Britton professor of epidemiology, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB |
| 13 |
Tobacco Harm Reduction Products Work, Study Shows
Written By: Dr. Sanjit Bagchi Published In: Health Care News > September 2007 Publication date: 09/01/2007 Publisher: The Heartland Institute |
| 14 |
Helping Smokers Quit: A Role for Smokeless Tobacco?
Written By: Kathleen Meister, M.A. Published In: News Releases > 2006 Publication date: 10/01/2006 Publisher: American Council on Science and Health |
| 15 |
Why Is Science Being Ignored?
Written By: Nick Baker Published In: Research & Commentary > 2007 Publication date: 02/26/2008 Publisher: The Heartland Institute |
| 16 |
You might as well smoke; the misleading and harmful public message about smokeless tobacco
by: Carl V Phillips*1,2,3, Constance Wang2 and Brian Guenzel3 Address: 1University of Texas Medical School, Center for Clinical Research and Evidence Based Medicine, Houston, USA, 2University of Texas School of Public Health, Houston, USA and 3Center for Philosophy, Health, and Policy Sciences, Inc., 10923 Atwell Dr, Houston, TX 77096, USA |
| 17 |
Tobacco and Tobacco Products at a Crossroads in the 21st Century
Written By: Scott D. Ballin Published In: Publication date: 08/01/2006 Publisher: The Eudoxa |
| 18 |
Harm Reduction Update - Let's Have An Honest and Objective Debate
Written By: Ed Whitfield Publication date: 05/15/2003 Publisher: Congress of the United States House of Representatives |
| 19 |
Give Facts A Chance: How a Campaign of Misinformation Deprives American Smokers of Facts They Should Hear About Smokeless Tobacco
Written By: Dr. Brad Rodu Published In: Organization Trends Publication date: 07/01/2004 Publisher: Capital Research Center |
| 20 |
Tobacco Harm Reduction Emerges as Viable Public Health Strategy
Written By: Sean Parnell Published In: Health Care News > September 2005 Publication date: 09/01/2005 |
| 21 |
Deconstructing anti-harm-reduction metaphors; mortality risk from falls and other traumatic injuries compared to smokeless tobacco use
Published: 18 April 2006 Harm Reduction Journal 2006, 3:15 doi:10.1186/1477-7517-3-15 Received: 19 September 2005 Accepted: 18 April 2006 © 2006 Phillips et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License |
| 22 |
Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines.
Richter P, Hodge K, Stanfill S, Zhang L, Watson C. Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA. pirl@cdc.gov |
| 23 |
The Dangerous Anti-Smoking Lobby: How Its “Quit-or-Die” Hostility to All Tobacco Products Harms Public Health
Written By: John K. Carlisle Published In: Organization Trends Publication date: 07/01/2003 Publisher: Capital Research Center |
| 24 |
Aging of Oral Moist Snuff (American Chewing Tobacco/Dip) and the Yields of TSNA's.
The concentration of the total TSNA in the leading U.S. moist oral snuff brands varies greatly, from 7.5 to 128 µg per g dry tobacco (Table 2). For comparison , a popular Swedish snus brand had even lower TSNA values (2.8 µg/g) than the lowest U.S. snuff brand. This demonstrates that snuff can be produced with low concentration of TSNA and with it, with a significantly reduced potential for carcinogenic activity. The technology clearly exists to manufacture snuff with low levels of TSNA, as shown by the Swedish. |
| 25 |
European Smokeless Tobacco Council (ESCOT) Response to SCENIHR - Scientic Support of Snus The European Smokeless Tobacco Council response, with scientific evidence, on the positive aspects of Scandinavian Snus. |
Page 1 of 2
